Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-29

FDA Approved: VIGADRONE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved Upsher-Smith Laboratories' original application for Vigadrone (vigabatrin), a generic form of the anticonvulsant vigabatrin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIGADRONE (VIGABATRIN)

Snippet

ORIG AP for VIGADRONE (VIGABATRIN)